Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Tinnitus - Overview
Tinnitus - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Tinnitus - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Tinnitus - Companies Involved in Therapeutics Development
AudioCure Pharma GmbH
Auris Medical Holding Ltd
Autifony Therapeutics Ltd
Cognosetta Inc
Gateway Biotechnology Inc
Knopp Biosciences LLC
Otonomy Inc
Sensorion SA
Tinnitus - Drug Profiles
AC-102 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AM-102 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AUT-3 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CS-0022 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Drugs for Tinnitus - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
esketamine hydrochloride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
gacyclidine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GW-103 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GW-201 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
KB-3061 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
RL-81 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Activate KCNQ2 and KCNQ3 for Tinnitus - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
tetrandrine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Tinnitus - Dormant Projects
Tinnitus - Discontinued Products
Tinnitus - Product Development Milestones
Featured News & Press Releases
Jun 16, 2021: Light E.N.T. announces first patient enrolled in drug trial for treatment of tinnitus (Ringing Sound in Ear)
Apr 05, 2021: Otonomy announces presentation of OTO-313 clinical results at American Neurotology Society Annual Meeting
Mar 25, 2021: Otonomy initiates phase 2 clinical trial of OTO-313 in Tinnitus
Nov 30, 2020: Otonomy provides update on OTO-313 program
Jul 06, 2020: Otonomy reports positive top-line results from phase 1/2 clinical trial of OTO-313 in patients with tinnitus
Jun 22, 2020: CogInc receives Bull Ring Accelerator Funding
Apr 08, 2020: CogInc awarded AOHL’s Flexi grant
Jan 10, 2020: Auris Medical announces notice of allowance for European Patent Application
Dec 17, 2019: Cognosetta: SBIR grant awarded
Sep 13, 2019: Auris Medical receives FDA and EMA Guidance for Keyzilen late-stage clinical development program
Aug 26, 2019: Auris Medical announces formation of scientific advisory board for tinnitus programs
May 23, 2019: Auris Medical provides update on Keyzilen
Apr 25, 2019: Auris Medical provides update on Tinnitus Drug Development Strategy
Apr 11, 2019: Otonomy initiates phase 1/2 Clinical Trial of OTO-313 in Tinnitus
Feb 06, 2019: Otonomy announces presentation on tinnitus drug OTO-313 at Association for Research in Otolaryngology Annual Meeting
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Tinnitus, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Targets, 2021
Number of Products by Stage and Targets, 2021
Number of Products by Mechanism of Actions, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Stage and Molecule Types, 2021

List of Tables

List of Tables
Number of Products under Development for Tinnitus, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Tinnitus - Pipeline by AudioCure Pharma GmbH, 2021
Tinnitus - Pipeline by Auris Medical Holding Ltd, 2021
Tinnitus - Pipeline by Autifony Therapeutics Ltd, 2021
Tinnitus - Pipeline by Cognosetta Inc, 2021
Tinnitus - Pipeline by Gateway Biotechnology Inc, 2021
Tinnitus - Pipeline by Knopp Biosciences LLC, 2021
Tinnitus - Pipeline by Otonomy Inc, 2021
Tinnitus - Pipeline by Sensorion SA, 2021
Tinnitus - Dormant Projects, 2021
Tinnitus - Discontinued Products, 2021